Tag - medicine-4

 
 

MEDICINE 4

Japan Times
COMMENTARY / World
Jul 22, 2021
At this point, the U.K.'s COVID-19 rules follow politics as much as science
If the last 18 months have taught us anything, it's that a successful COVID-19 policy requires three things: high levels of public trust, a coherent strategy and effective implementation.
Japan Times
COMMENTARY / World
Jul 21, 2021
As delta variant rages in Southeast Asia, health workers warned not to speak out
In Southeast Asian nations, health care providers calling for stronger job security and better protection against variants of the coronavirus, have put governments on the defensive.
Japan Times
WORLD / FOCUS
Jul 16, 2021
World carved up into haves and have-nots by mRNA vaccine access
The cutting-edge technology, which made its debut during the pandemic, has proven more effective than any other in staving off infections and serious illness from the coronavirus.
Japan Times
BUSINESS / Companies
Jul 13, 2021
Eisai pushes second Alzheimer's drug despite call to probe U.S. approval of first
The U.S. Food and Drug Administration's June approval of Aduhelm caused resignations among a panel of independent experts who said the therapy was ineffective.
Japan Times
WORLD
Jul 9, 2021
Pfizer outlines booster plans while regulators signal caution
Pfizer Inc. plans to request U.S. emergency authorization in August for a third booster dose of its COVID-19 vaccine.
Japan Times
WORLD
Jul 9, 2021
Countries using Chinese-made vaccines and AstraZeneca increasingly eye boosters
Officials are being motivated by concerns that delta and other variants appear to be breaking down defenses of vaccines not made from the supereffective messenger RNA technology.
Japan Times
WORLD / Science & Health
Jul 7, 2021
Studies show vaccines are effective against delta variant
Jerusalem, however, announced that the effectiveness of the Pfizer-BioNTech vaccine was seen to be 64% against all COVID-19 infections — down from about 95% in May.
Japan Times
JAPAN
Jun 29, 2021
In Japan, anti-vaccine movement threatens to make widespread hesitancy worse
“Zero-risk worship” in Japan has made experts concerned about the impact that a fringe community of outspoken vaccine opponents could have on the public.
Japan Times
WORLD
Jun 28, 2021
Pfizer and Moderna vaccines likely produce long-lasting immunity
The findings add to growing evidence that most people immunized with mRNA vaccines may not need boosters, so long as the virus and its variants do not evolve much.
Japan Times
WORLD
Jun 25, 2021
WHO estimates COVID-19 boosters needed yearly for most vulnerable
A document shows that the WHO considers annual boosters for high-risk individuals as its 'indicative' baseline scenario, and boosters every two years for the general population.
Japan Times
COMMENTARY / World
Jun 22, 2021
Face masks were a booming business. Until they weren’t.
Face masks were the most ubiquitous visual symbol of the COVID-19 pandemic, but they're fading from sight as more and more people get vaccinated.
Japan Times
COMMENTARY / World
Jun 21, 2021
A scary plan to revise the definition of death in the U.S.
The current law's silence about how brain death is diagnosed means that someone could be found legally dead in Nevada even if ruled alive in Kansas.
Japan Times
WORLD
Jun 21, 2021
COVID-19 counting enters new era as threat shifts away from cases
With rich countries vaccinating growing proportions of their vulnerable populations, the link between infection numbers and deaths appears to be diminishing.
Japan Times
JAPAN / Science & Health
Jun 20, 2021
The Japanese scientist fighting prejudice, misinformation and COVID-19
Akiko Iwasaki is leading a team of immunologists hoping to beat 'long COVID-19' while also debunking myths surrounding the coronavirus.
Japan Times
WORLD / Science & Health
Jun 16, 2021
Regeneron drug reduces COVID-19 patient deaths in large study
The results suggest there would be six fewer deaths over 28 days for every 100 patients given the company's casirivimab and imdevimab combination of monoclonal antibodies.
Japan Times
COMMENTARY / World
Jun 14, 2021
Alzheimer’s drug furor highlights U.S. health system’s failures
The FDA didn't deny that the clinical-trial evidence was poor. It simply ignored that problem and used different reasoning to grant the drug 'accelerated approval.”
Japan Times
WORLD / Science & Health / ANALYSIS
Jun 11, 2021
U.S. FDA faces mounting criticism over Alzheimer's drug approval
The drug was authorized based on evidence that it can reduce brain plaques, a likely contributor to Alzheimer's, rather than proof that it slows progression of the disease.

Longform

Construction takes place on the Takanawa Gateway Convention Center in Tokyo, slated to open in 2025.
A boom for business tourism in Japan?